The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes and facilities. Under the pilot program, facilities that use fixed-chamber ethylene oxide sterilization processes to sterilize single-use medical devices would submit a “master file” to the FDA when making certain changes to their location or changes to their sterilization processes that use lower ethylene oxide concentrations. The FDA believes the program will allow more efficient review and feedback, ultimately allowing the agency to provide a more nimble response to site closures in the future. In addition, FDA said it will work with 12 applicants to its innovation challenges to accelerate the development and review of innovative technologies for sterilization processes, and is moving forward with certain recommendations from its recent advisory committee meeting.

Related News Articles

Headline
The FBI today released recommendations to help protect medical devices from cyberattacks that can threaten health care operations, patient safety, and…
Headline
Philips Respironics has recalled more than 17 million masks used with Bilevel Positive Airway Pressure and Continuous Positive Airway Pressure machines because…
Headline
The AHA last week encouraged the Bureau of Land Management to work with the Health and Human Services Assistant Secretary for Preparedness and Response,…
Headline
The Food and Drug Administration yesterday provided an update on the HeartWare Ventricular Assist Device system. These updates include new recommendations for…
Headline
The Food and Drug Administration today announced a Class 1 recall of devices used to access blood vessels through a patient’s bone because the devices may…
Headline
The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions…